234 filings
Page 5 of 12
8-K
4yp3xs i2srt1uq
29 Oct 20
Other Events
5:28pm
424B5
0heht8r470 npnq13q
29 Oct 20
Prospectus supplement for primary offering
5:25pm
424B5
w7duxhc8nzg
28 Oct 20
Prospectus supplement for primary offering
5:29pm
424B5
bmud65qo q4
28 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
9hot2yh t9hsevwf320s
9 Sep 20
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data In Science Translational Medicine
4:06pm
424B5
6cdf2jw6j8rw5atd5
4 Sep 20
Prospectus supplement for primary offering
4:51pm
8-K
udml3lxw6xrsqs y8
4 Sep 20
Audited Financial Statements
4:31pm
S-8
1drwu1yti
11 Aug 20
Registration of securities for employees
5:19pm
8-K
yys7tukpw3nnpvvw
10 Aug 20
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
4:04pm
8-K/A
oodtjqiz
10 Aug 20
Financial Statements and Exhibits
4:02pm
8-K
kugpxrwejm01vgc0 prl
21 Jul 20
Changes in Registrant's Certifying Accountant
4:34pm
8-K
ostwrfv
26 Jun 20
Regulation FD Disclosure
5:09pm
8-K
g2dezmsffufc
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
8-K
6v00pu6rfcmw3
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
aueh8jlxy73g
8 Jun 20
Other Events
5:25pm
DEFA14A
ldgefbb771n1a21
28 May 20
Additional proxy soliciting materials
4:57pm
EFFECT
19tdw0we
14 May 20
Notice of effectiveness
12:15am
424B3
zfct3z qmmb
14 May 20
Prospectus supplement
12:00am